XML 24 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Assets:    
Cash and cash equivalents $ 8,442 $ 9,408
Investments 2,900 3,117
Accounts receivable, net 26,451 24,431
Inventories 18,160 17,760
Other current assets 5,530 5,292
Total current assets 61,483 60,008
Long-term investments 22,595 23,025
Property and equipment, net 12,844 12,896
Operating lease right-of-use assets 18,801 19,122
Goodwill 79,060 79,121
Intangible assets, net 28,543 29,026
Separate accounts assets 4,670 5,087
Other assets 4,877 4,714
Total assets 232,873 232,999
Liabilities:    
Accounts payable 12,738 12,544
Pharmacy claims and discounts payable 18,572 17,330
Health care costs payable 10,260 8,808
Policyholders’ funds 4,138 4,301
Accrued expenses 16,619 17,670
Other insurance liabilities 1,387 1,303
Current portion of operating lease liabilities 1,849 1,646
Current portion of long-term debt 4,217 4,205
Total current liabilities 69,780 67,807
Long-term operating lease liabilities 17,786 18,177
Long-term debt 52,063 51,971
Deferred income taxes 5,829 6,270
Separate accounts liabilities 4,670 5,087
Other long-term insurance liabilities 6,363 6,402
Other long-term liabilities 2,242 1,904
Total liabilities 158,733 157,618
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,747 shares issued and 1,306 shares outstanding at March 31, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus 47,677 47,377
Treasury stock, at cost: 441 shares at March 31, 2022 and 422 shares at December 31, 2021 (30,145) (28,173)
Retained earnings 56,488 54,906
Accumulated other comprehensive income (loss) (190) 965
Total CVS Health shareholders’ equity 73,830 75,075
Noncontrolling interests 310 306
Total shareholders’ equity 74,140 75,381
Total liabilities and shareholders’ equity $ 232,873 $ 232,999